GADEWAR, M., and B. LAL. “MOLECULAR DOCKING AND SCREENING OF DRUGS FOR 6LU7 PROTEASE INHIBITOR AS A POTENTIAL TARGET FOR COVID-19”. International Journal of Applied Pharmaceutics, vol. 14, no. 1, Jan. 2022, pp. 100-5, doi:10.22159/ijap.2022v14i1.43132.